Top Markets
#1 Ontology Gas Ontology Gas +30.80%
#2 EXOD EXOD +22.08%
#3 Status Status +21.90%
#4 ETHGas ETHGas +19.74%
#5 The Black Bull The Black Bull +17.98%
#6 Anvil Anvil +12.83%
#7 Fake World Assets Fake World Assets +10.94%
#8 aelf aelf +9.61%
#9 Gas Gas +9.27%
#10 Derive Derive +8.79%
Coin of the day
Ontology Gas Ontology Gas
設定
言語
日本
通貨
USD
テーマ
Mendus AB (publ) Mendus AB (publ)

Mendus AB (publ)

IMMU
株式のランク #25825
Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB... Mendus AB (publ), a biopharmaceutical entity formerly known as Immunicum AB (publ) until its name change in June 2022, specializes in developing immunotherapies and vaccines designed to prevent cancer recurrence. Its primary investigational compound, ilixadencel, is currently progressing through a Phase II MERECA clinical study for kidney cancer, alongside Phase I/II trials targeting liver cancer and gastrointestinal stromal tumors. Additionally, the company is advancing DCP-001, which is undergoing Phase II ADVANCE-II clinical research for acute myeloid leukemia and Phase I/II ALISON trials for ovarian cancers. Mendus maintains research partnerships with PCI Biotech Holding ASA to explore novel cancer vaccination approaches and with the Icahn School of Medicine at Mount Sinai. Founded in 2002, Mendus AB is headquartered in Stockholm, Sweden.
株価
$0.74834668
最終同期: 2026-08-20
時価総額
$45.86M
変化（1日）
-0.15%
変化（1年）
-2.71%
国
SE
取引 Mendus AB (publ) (IMMU)

カテゴリー

Healthcare
Mendus AB (publ)（IMMU）の配当履歴
Mendus AB (publ)（証券コード：IMMU）は合計で0回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：0.00
配当利回り（TTM）：0
2026から2026までのMendus AB (publ)（IMMU）の配当履歴
年間配当支払い
年 配当（株式分割調整済み） 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
年 配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴
企業 配当支払い回数 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US